1
|
Siguier PLM, Planton M, Baudou E, Chaix Y, Delage A, Rafiq M, Wolfrum M, Gérard F, Jucla M, Pariente J. Can neurodevelopmental disorders influence the course of neurodegenerative diseases? A scoping review. Ageing Res Rev 2024; 99:102354. [PMID: 38857707 DOI: 10.1016/j.arr.2024.102354] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/06/2024] [Revised: 04/30/2024] [Accepted: 05/27/2024] [Indexed: 06/12/2024]
Abstract
This scoping review aims at giving an overview of the possible influence of neurodevelopmental disorders (NDDs) on cognitive-behavioral neurodegenerative diseases (CBNDs). Based on the PRISMA-ScR checklist, it details the methods of NDDs screening, the identified NDDs-CBNDs associations, as well as the criteria and types of association. The last literature search was performed in June 2023. In the final study, 32 articles were included. Analysis first showed that NDDs were mainly detected through medical records screening. Second, the association of specific learning disorders and major or mild neurocognitive disorder due to Alzheimer's disease was the most investigated. Third, associations were mostly based on prevalence comparisons. Finally, 66 % of studies reported a positive association between NDDs and CBNDs. Notably, up to 67 % of positive associations were observed with atypical forms of certain CBNDs. Authors' interpretations suggest that NDDs could constitute a risk factor for CBNDs. However, the influence of NDDs on CBNDs still lacks evidence and biological support, possibly due to the heterogeneity of methods and criteria employed. Developing validated assessment tools for all NDDs and conducting cohort studies could be beneficial for research, and clinical practice. Indeed, this review also underlines the importance of adopting a life-span approach regarding CBNDs.
Collapse
Affiliation(s)
- Perrine L M Siguier
- Toulouse NeuroImaging Center, UMR1214, Toulouse University III, Inserm, CHU PURPAN - Pavillon BAUDOT, Place du Dr Joseph Baylac, 31024 TOULOUSE cedex 3, France; Laboratoire de Neuropsycholinguistique, EA4156, University of Toulouse II, 5 allée Antonio Machado, 31058 TOULOUSE cedex 9, France.
| | - Mélanie Planton
- Toulouse NeuroImaging Center, UMR1214, Toulouse University III, Inserm, CHU PURPAN - Pavillon BAUDOT, Place du Dr Joseph Baylac, 31024 TOULOUSE cedex 3, France; Department of Neurology, Neuroscience Centre, Toulouse-Purpan University Hospital, Place du Dr Baylac, TSA 40 031, 31059 Toulouse cedex 9, France
| | - Eloise Baudou
- Toulouse NeuroImaging Center, UMR1214, Toulouse University III, Inserm, CHU PURPAN - Pavillon BAUDOT, Place du Dr Joseph Baylac, 31024 TOULOUSE cedex 3, France; Neuropediatric Department, Toulouse-Purpan University Hospital, 330 avenue de Grande Bretagne - TSA 70034 - 31059 Toulouse cedex 9, France
| | - Yves Chaix
- Toulouse NeuroImaging Center, UMR1214, Toulouse University III, Inserm, CHU PURPAN - Pavillon BAUDOT, Place du Dr Joseph Baylac, 31024 TOULOUSE cedex 3, France; Neuropediatric Department, Toulouse-Purpan University Hospital, 330 avenue de Grande Bretagne - TSA 70034 - 31059 Toulouse cedex 9, France
| | - Alix Delage
- MéD@tAS Unit, Clinical Investigation Centre INSERM 1436, Department of Medical and Clinical Pharmacology, Toulouse University Hospital, 37 Allées Jules Guesde, Toulouse 31000, France
| | - Marie Rafiq
- Department of Neurology, Neuroscience Centre, Toulouse-Purpan University Hospital, Place du Dr Baylac, TSA 40 031, 31059 Toulouse cedex 9, France
| | - Marie Wolfrum
- Department of Neurology, Neuroscience Centre, Toulouse-Purpan University Hospital, Place du Dr Baylac, TSA 40 031, 31059 Toulouse cedex 9, France
| | - Fleur Gérard
- Department of Neurology, Neuroscience Centre, Toulouse-Purpan University Hospital, Place du Dr Baylac, TSA 40 031, 31059 Toulouse cedex 9, France
| | - Mélanie Jucla
- Laboratoire de Neuropsycholinguistique, EA4156, University of Toulouse II, 5 allée Antonio Machado, 31058 TOULOUSE cedex 9, France
| | - Jérémie Pariente
- Toulouse NeuroImaging Center, UMR1214, Toulouse University III, Inserm, CHU PURPAN - Pavillon BAUDOT, Place du Dr Joseph Baylac, 31024 TOULOUSE cedex 3, France; Department of Neurology, Neuroscience Centre, Toulouse-Purpan University Hospital, Place du Dr Baylac, TSA 40 031, 31059 Toulouse cedex 9, France
| |
Collapse
|
2
|
Hedges DW, Chase M, Farrer TJ, Gale SD. Psychiatric Disease as a Potential Risk Factor for Dementia: A Narrative Review. Brain Sci 2024; 14:722. [PMID: 39061462 PMCID: PMC11274614 DOI: 10.3390/brainsci14070722] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/24/2024] [Revised: 07/10/2024] [Accepted: 07/16/2024] [Indexed: 07/28/2024] Open
Abstract
Neurodegenerative disease is a major global health problem with 150 million people predicted to have dementia by 2050. Genetic factors, environmental factors, demographics, and some diseases have been associated with dementia. In addition to associations between diseases such as hypertension and cerebrovascular disease and dementia, emerging findings associate some psychiatric disorders with incident dementia. Because of the high and increasing global prevalence of dementia and the high worldwide prevalence of psychiatric disorders, the primary objective of this narrative review was to evaluate published findings that evaluate the association between bipolar disorder, depression, anxiety, post-traumatic stress disorder, obsessive-compulsive disorder, attention-deficit/hyperactivity disorder, autism spectrum disorder, schizophrenia and other psychosis syndromes, and personality disorders and personality traits and incident dementia. Here, we highlight findings indicating possible associations between these psychiatric disorders and subsequent dementia and suggest that some psychiatric disorders may be risk factors for incident dementia. Further research, including more large longitudinal studies and additional meta-analyses, however, is needed to better characterize the associations between psychiatric disorders and incident dementia, to identify possible mechanisms for these putative associations, and to identify risk factors within psychiatric disorders that predispose some people with a psychiatric disorder but not others to subsequent dementia. Additional important questions concern how the treatment of psychiatric disorders might affect the risk of incident dementia.
Collapse
Affiliation(s)
- Dawson W. Hedges
- The Department of Psychology, Brigham Young University, Provo, UT 84602, USA;
- The Neuroscience Center, Brigham Young University, Provo, UT 84602, USA;
| | - Morgan Chase
- The Neuroscience Center, Brigham Young University, Provo, UT 84602, USA;
| | - Thomas J. Farrer
- Idaho WWAMI Medical Education Program, University of Idaho, Moscow, ID 83844, USA;
| | - Shawn D. Gale
- The Department of Psychology, Brigham Young University, Provo, UT 84602, USA;
- The Neuroscience Center, Brigham Young University, Provo, UT 84602, USA;
| |
Collapse
|
3
|
Golimstok Á, Basalo MJG, Majul M, Berrios W, Rugiero M, Fernández MC, Eichel R. Adult Attention Deficit-Hyperactivity Disorder is associated with Lewy Body Disease and Cognitive Impairment: A prospective cohort Study With 15-year Follow-Up. Am J Geriatr Psychiatry 2024:S1064-7481(24)00304-X. [PMID: 38697886 DOI: 10.1016/j.jagp.2024.04.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/09/2024] [Revised: 04/08/2024] [Accepted: 04/08/2024] [Indexed: 05/05/2024]
Abstract
OBJECTIVES Past reports have suggested that attention-deficit/hyperactivity disorder (ADHD) may be a risk factor for Lewy body disease (LBD). To confirm this relationship, we conducted the present study. DESIGN A prospective observational cohort study with a follow-up to 15 years. SETTING The subjects were recruited from cognitive neurology clinics, where they attended for a cognitive complaint or health check-up. PARTICIPANTS Two groups of subjects: ADHD adults and healthy subjects. MEASUREMENTS The risk of dementia and LBD was estimated with Kaplan-Meier analysis comparing for the presence or absence of ADHD with the log-rank test. Predictors of conversion were assessed through separate univariate and multivariate Cox regression analyses, adjusting for several variables. RESULTS The baseline sample consisted of 161 subjects with ADHD and 109 without ADHD. At the end of the follow-up, 31 subjects developed dementia, 27 cases in the ADHD group and 4 in comparison group. Dementia with Lewy bodies (DLB) was the most frequent type (N:20) of which 19 corresponded to the ADHD group. The incidence of non-amnestic-MCI in the ADHD group was higher representing 67.1 % of these subjects (N:108), and 17.4% (N:19) of healthy cases. The hazard ratios for dementia and LBD in the multivariate adjusted model were 3.33 (95% CI 1.0915 to 10.1699) and 54.54 (95% CI 7.4849 to 397.5028), respectively in the ADHD group. CONCLUSIONS This study showed that adult ADHD is independently associated with an increased risk of LBD, dementia, and na-MCI. Future studies should clarify this relationship to develop preventive measures for these patients.
Collapse
Affiliation(s)
- Ángel Golimstok
- Cognitive and Behavior Unit, Department of Neurology (AG, MJGB, MM, WB, MR, MCF), Hospital Italiano de Buenos Aires, Buenos Aires, Argentina; Master of Neuropsychology (AG, MJGB, MM, WB, MCF), University Institute of the Italian Hospital, Buenos Aires, Argentina.
| | - María José García Basalo
- Cognitive and Behavior Unit, Department of Neurology (AG, MJGB, MM, WB, MR, MCF), Hospital Italiano de Buenos Aires, Buenos Aires, Argentina; Master of Neuropsychology (AG, MJGB, MM, WB, MCF), University Institute of the Italian Hospital, Buenos Aires, Argentina
| | - Mariana Majul
- Cognitive and Behavior Unit, Department of Neurology (AG, MJGB, MM, WB, MR, MCF), Hospital Italiano de Buenos Aires, Buenos Aires, Argentina; Master of Neuropsychology (AG, MJGB, MM, WB, MCF), University Institute of the Italian Hospital, Buenos Aires, Argentina
| | - Waleska Berrios
- Cognitive and Behavior Unit, Department of Neurology (AG, MJGB, MM, WB, MR, MCF), Hospital Italiano de Buenos Aires, Buenos Aires, Argentina; Master of Neuropsychology (AG, MJGB, MM, WB, MCF), University Institute of the Italian Hospital, Buenos Aires, Argentina
| | - Marcelo Rugiero
- Cognitive and Behavior Unit, Department of Neurology (AG, MJGB, MM, WB, MR, MCF), Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
| | - Maria Cecilia Fernández
- Cognitive and Behavior Unit, Department of Neurology (AG, MJGB, MM, WB, MR, MCF), Hospital Italiano de Buenos Aires, Buenos Aires, Argentina; Master of Neuropsychology (AG, MJGB, MM, WB, MCF), University Institute of the Italian Hospital, Buenos Aires, Argentina
| | - Roni Eichel
- Department of Neurology (RE), Shaare Zedek Medical Center, Jerusalem, Israel; The School of Medicine (RE), The Hebrew University, Jerusalem, Israel
| |
Collapse
|